Weixinkang Pharmaceutical multivitamin Injection (13) (10/3) approved for listing!

Recently, Xizang Zhongwei Chengkang Pharmaceutical Co., LTD., a wholly-owned subsidiary of Weixinkang Pharmaceutical, received the Drug Registration Certificate of multivitamin injection (13) (10/3) approved and issued by the State Drug Administration (drug approval number: Sinofin H20234276). According to the relevant national policies and regulations, the acquisition of the "Drug Registration Certificate" is regarded as passing the consistency evaluation.

In the future, Weixinkang Medicine will continue to focus on clinical needs, focus on innovation in the pharmaceutical field, and strive to improve the accessibility of high-quality drugs to serve a healthy and beautiful life!

Relevant information

The drug is a compound preparation composed of 13 vitamins and is an intravenous parenteral nutrition drug. It is suitable for the prevention of vitamin deficiency in adults and children aged 11 years and above receiving parenteral nutrition.